000 01672 a2200457 4500
005 20250517094123.0
264 0 _c20180130
008 201801s 0 0 eng d
022 _a2213-8595
024 7 _a10.1016/S2213-8587(16)00112-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWallis, Christopher J D
245 0 0 _aSurvival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
_h[electronic resource]
260 _bThe lancet. Diabetes & endocrinology
_c06 2016
300 _a498-506 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAndrogens
_xadministration & dosage
650 0 4 _aCardiovascular Diseases
_xchemically induced
650 0 4 _aCase-Control Studies
650 0 4 _aCohort Studies
650 0 4 _aHormone Replacement Therapy
_xadverse effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOntario
_xepidemiology
650 0 4 _aProstatic Neoplasms
_xchemically induced
650 0 4 _aTestosterone
_xadministration & dosage
700 1 _aLo, Kirk
700 1 _aLee, Yuna
700 1 _aKrakowsky, Yonah
700 1 _aGarbens, Alaina
700 1 _aSatkunasivam, Raj
700 1 _aHerschorn, Sender
700 1 _aKodama, Ronald T
700 1 _aCheung, Patrick
700 1 _aNarod, Steven A
700 1 _aNam, Robert K
773 0 _tThe lancet. Diabetes & endocrinology
_gvol. 4
_gno. 6
_gp. 498-506
856 4 0 _uhttps://doi.org/10.1016/S2213-8587(16)00112-1
_zAvailable from publisher's website
999 _c26007270
_d26007270